Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $432.89 | 36 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $304.78 | 27 | $0 (2018) |
| PFIZER INC. | $39.28 | 3 | $0 (2018) |
| Janssen Pharmaceuticals, Inc | $37.53 | 2 | $0 (2017) |
| Novartis Pharmaceuticals Corporation | $27.29 | 2 | $0 (2017) |
| Alkermes, Inc. | $12.29 | 1 | $0 (2017) |
| Indivior Inc. | $11.72 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2018 | $145.73 | 16 | E.R. Squibb & Sons, L.L.C. ($117.45) |
| 2017 | $287.16 | 20 | E.R. Squibb & Sons, L.L.C. ($187.33) |
All Payment Transactions
36 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $8.59 | General |
| Category: Cardiovascular | ||||||
| 12/19/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $5.69 | General |
| Category: Cardiovascular | ||||||
| 11/08/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.19 | General |
| Category: Cardiovascular | ||||||
| 09/26/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $11.13 | General |
| Category: Cardiovascular | ||||||
| 08/28/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $5.60 | General |
| Category: Cardiovascular | ||||||
| 08/02/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $6.15 | General |
| Category: Cardiovascular | ||||||
| 06/20/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.82 | General |
| Category: Cardiovascular | ||||||
| 06/04/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $5.96 | General |
| Category: Cardiovascular | ||||||
| 04/26/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $9.56 | General |
| Category: Cardiovascular | ||||||
| 04/10/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $9.23 | General |
| Category: Cardiovascular | ||||||
| 04/05/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 03/20/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $5.50 | General |
| Category: Cardiovascular | ||||||
| 03/13/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $6.40 | General |
| Category: Cardiovascular | ||||||
| 02/13/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $5.14 | General |
| Category: Cardiovascular | ||||||
| 01/19/2018 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.49 | General |
| Category: Cardiovascular | ||||||
| 01/03/2018 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $12.70 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 12/20/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $12.93 | General |
| Category: Cardiovascular | ||||||
| 12/07/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $4.45 | General |
| Category: Cardiovascular | ||||||
| 11/30/2017 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 11/10/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $6.10 | General |
| Category: Cardiovascular | ||||||
| 10/10/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $14.19 | General |
| Category: Cardiovascular | ||||||
| 09/13/2017 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $11.05 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/30/2017 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $7.24 | General |
| Category: Cardiovascular | ||||||
| 08/16/2017 | Indivior Inc. | SUBOXONE SUBLINGUAL FILM (Drug) | Food and Beverage | Cash or cash equivalent | $11.72 | General |
| Category: OUD | ||||||
| 08/02/2017 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $11.00 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 765 | 1,185 | $245,780 | $95,236 |
| 2022 | 8 | 924 | 1,422 | $330,112 | $113,020 |
| 2021 | 8 | 766 | 1,231 | $327,559 | $100,628 |
| 2020 | 8 | 878 | 1,380 | $384,180 | $115,418 |
All Medicare Procedures & Services
30 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 201 | 356 | $81,427 | $32,185 | 39.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 212 | 470 | $65,002 | $28,031 | 43.1% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 204 | 208 | $45,153 | $17,753 | 39.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 104 | 107 | $45,068 | $13,697 | 30.4% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 24 | 24 | $6,294 | $2,394 | 38.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 20 | 20 | $2,837 | $1,175 | 41.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 179 | 397 | $96,845 | $31,809 | 32.8% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 223 | 472 | $71,323 | $25,989 | 36.4% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 133 | 136 | $60,056 | $20,902 | 34.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 209 | 218 | $50,876 | $17,656 | 34.7% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 55 | 56 | $23,100 | $7,945 | 34.4% |
| 99217 | Hospital observation care on day of discharge | Facility | 2022 | 70 | 70 | $12,250 | $3,777 | 30.8% |
| 99226 | Follow-up observation care per day, typically 35 minutes | Facility | 2022 | 30 | 38 | $9,830 | $3,027 | 30.8% |
| 99225 | Follow-up observation care per day, typically 25 minutes | Facility | 2022 | 25 | 35 | $5,832 | $1,914 | 32.8% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 191 | 429 | $114,056 | $35,259 | 30.9% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 172 | 358 | $66,814 | $20,238 | 30.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 104 | 107 | $54,979 | $16,583 | 30.2% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 136 | 145 | $38,447 | $12,186 | 31.7% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 51 | 52 | $24,073 | $7,334 | 30.5% |
| 99226 | Subsequent observation care, typically 35 minutes per day | Facility | 2021 | 35 | 43 | $11,226 | $3,536 | 31.5% |
| 99225 | Subsequent observation care, typically 25 minutes per day | Facility | 2021 | 31 | 50 | $9,365 | $2,862 | 30.6% |
| 99217 | Hospital observation care on day of discharge | Facility | 2021 | 46 | 47 | $8,600 | $2,630 | 30.6% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 198 | 444 | $126,574 | $37,033 | 29.3% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 180 | 388 | $75,451 | $22,586 | 29.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 122 | 127 | $68,181 | $20,508 | 30.1% |
About Dr. Fraol Adugna, MD
Dr. Fraol Adugna, MD is a Internal Medicine healthcare provider based in Troy, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/21/2008. The National Provider Identifier (NPI) number assigned to this provider is 1134386519.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Fraol Adugna, MD has received a total of $432.89 in payments from pharmaceutical and medical device companies, with $145.73 received in 2018. These payments were reported across 36 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($432.89).
As a Medicare-enrolled provider, Adugna has provided services to 3,333 Medicare beneficiaries, totaling 5,218 services with total Medicare billing of $424,302. Data is available for 4 years (2020–2023), covering 30 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Troy, OH
- Active Since 05/21/2008
- Last Updated 03/02/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1134386519
Products in Payments
- ELIQUIS (Drug) $344.06
- XARELTO (Drug) $37.53
- ENTRESTO (Drug) $27.29
- Vivitrol 380 mg (Drug) $12.29
- SUBOXONE SUBLINGUAL FILM (Drug) $11.72
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Troy
Dr. Neil Fraser, Md, MD
Internal Medicine — Payments: $180,276
Dr. John Calado, Do, DO
Internal Medicine — Payments: $152,221
Michael Doyle, Md, MD
Internal Medicine — Payments: $85,884
Dr. Jay Sandberg, D.o, D.O
Internal Medicine — Payments: $28,867
Dr. Mohammed Kabir, Md, MD
Internal Medicine — Payments: $26,648
Dr. Noor Bunney, Md, MD
Internal Medicine — Payments: $21,394